A previous study has reported that S100A12 levels in the lung, bronchoalveolar lavage fluid (BALF), and serum were increased in acute respiratory distress syndrome (ARDS) patients compared to healthy controls (Lorenz et al., 2008; Kikkawa et al., 2010). The gene discussed is S100A12; the disease is acute respiratory distress syndrome.